ArticleApplied biochemistry and biotechnology2025
A Streamlined One-Step Bioprocess for Isomaltulose Production in Bacillus subtilis Through Multicopy Genomic Integration of Sucrose Isomerase Gene.
Article in Applied biochemistry and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advances in erythritol production through synthetic biology and systems metabolic engineering.Archives of microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Isomaltulose, a sucrose isomer with a low glycemic index and non-cariogenic properties, is extensively used in the food industry. The industrial production of this functional sugar relies on enzymatic biotransformation using sucrose isomerase (SIase). However, conventional bioprocesses involve expressing and isolating the SIase enzyme, followed by using the purified SIase to convert sucrose into isomaltulose, resulting in a multi-step and high-cost process that hindered the broader applications of isomaltulose. In this study, we reported a streamlined one-step bioprocess that integrates extracellular SIase secretion and direct isomaltulose biosynthesis in the culture medium of an engineered B. subtilis strain. Using CRISPR/Cas9 technology, we engineered B. subtilis to integrate multiple SIase expression cassettes into the genome while concurrently replacing genes within the sacP-sacA-ywdA and sacB-levB-yveA operons, which are crucial for sucrose hydrolysis in B. subtilis. This strategy synergistically increased the genomic copy number of SIase gene while limited sucrose consumption by native pathways, thereby maximizing substrate availability for SIase-mediated catalysis. The resulting engineered strain, containing four copies of the SIase expression cassettes, achieved an extracellular SIase activity of 8.2 U/mL in shake flasks. When cultured in a medium containing 200 g/L sucrose, this strain produced a maximum isomaltulose titer of 162.1 g/L with a yield of 0.81 g/g and a productivity of 13.5 g/L/h. These findings demonstrate an integrated bioprocess that eliminates costly enzyme isolation procedure and reduces fermentation complexity, presenting a commercially feasible strategy for sustainable isomaltulose production.
Indexed as
Identifiers
40810834What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.